Diferences in the expression of apoptotic proteins in Burkitt's lymphoma cell lines: Potential models for screening apoptosis-inducing agents

Leukemia and Lymphoma

Volumn 45, Issue 2, 2004, Pages 357-362

  Doucet, Jean Pierre ^a   Hussain, Azhar ^a   al Rasheed, Maha ^a   Gaidano, Gianluca ^b   Gutiérrez, Marina I ^a   Magrath, Ian ^c   Bhatia, Kishor ^a,c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Intl Network Cancer Treatment/Res   (Belgium)

Author keywords

Apoptosis; Bcl 2; Caspases; IAP; MAP kinase; Non Hodgkin's lympoma

Indexed keywords

ANTINEOPLASTIC AGENT; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL X; PROTEIN P53; BIRC2 PROTEIN, HUMAN; BIRC4 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN PRECURSOR; TUMOR PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER GROWTH; CARCINOGENESIS; CELL INTERACTION; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCREENING; TUMOR MODEL; GENE EXPRESSION REGULATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BURKITT LYMPHOMA; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MAP KINASE SIGNALING SYSTEM; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTEIN PRECURSORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0842322866     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001595713     Document Type: Article

References (32)

1. Balint, E.E. and Vousden, K.H. (2001) "Activation and activities of the p53 tumour suppressor protein", British Journal of Cancer, 85, 1813-1823.
2. Ashkenazi, A. and Dixit, V.M. (1999) "Death receptors: signaling and modulation", Science, 281, 1305-1308.
3. Sheridan, J.P., Marsters, S.A., Pitti, R.M., Gurney, A., Skutbatch, M., Baldwin, D., et al. (1997) "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors", Science, 277, 818-821.
4. Peter, M.E. and Krammer, P.H. (1998) "Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis", Current Opinion in Immunology, 5, 545-551.
5. Koncz, G., Bodor, C., Kovesdi, D., Gati, R. and Sarmay, G. (2002) "BCR mediated signal transduction in immature and mature B cells", Immunological Letters, 82, 41-49.
6. Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., et al. (2001) "Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death", Science, 292, 727-730.
7. Zou, H., Li, Y., Liu, X. and Wang, X. (1999) "An APAF-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9", Journal of Biological Chemistry, 274, 11549-11556.
8. Debatin, K.M., Poncet, D. and Kroemer, G. (2002) "Chemotherapy: targeting the mitochondrial cell death pathway", Oncogene, 21, 8796-8803.
9. Sun, X.M., Bratton, S.B., Butterworth, M., MacFarlane, M. and Cohen, G.M. (2002) "Bcl-2 and Bcl-X1 inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein", Journal of Biological Chemistry, 277, 11345-11351.
10. Roy, N., Deveraux, Q.L., Takahashi, R., Salvesan, G.S. and Reed, J.C. (1997) "The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases", The EMBO Journal, 16, 6914-6925.
11. Ambrosini, G., Adida, C. and Altieri, D.C. (1997) "A novel anti-apoptotic gene, surviving, expressed in cancer and lymphoma", Nature Medicine, 3, 917-921.
12. Klumpp, S. and Krieglstein, J. (2002) "Serine/threonine protein phosphatases in apoptosis", Current Opinion in Cancer, 2, 458-462.
13. Shohat, G., Spivak-Kroizman, T., Eisenstein, M. and Kimchi, A. (2002) "The regulation of death-associated protein (DAP) kinase in apoptosis", European Cytokine Network, 13, 387-395.
14. Boldt, S., Weidle, U.H. and Kolch, W. (2002) "The role of MAPK pathways in the action of chemotherapeutic drugs", Carcinogenesis, 23, 1831-1838.
15. Li, W. and Bertino, J.R. (2002) "Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase", Molecular Cancer Therapy, 1, 1343-1348.
16. Swart, J.M. and Chiles, T.C. (2000) "Rescue of CH31 B cells from antigen receptor-induced apoptosis by inhibition of p38 MAPK", Biochemistry and Biophysical Research Communications, 276, 417-421.
17. Ogata, S., Takeuchi, M., Fujita, H., Shibata, K., Okumura, K. and Taguchi, H. (2000) "Apoptosis induced by niacin-related compounds in K562 cells but not in normal human lymphocytes", Bioscience Biotechnology and Biochemistry, 64, 1142-1146.
18. Lecureur, V., Le Thiec, A., Le Meur, A., Amiot, L., Drenou, B., Bernard, M., et al. (2002). "Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells", British Journal of Haematology, 119, 608-615.
19. Tsan, M.F., White, J.E., Maheshwari, J.G. and Chikkappa, G. (2002) "Anti-leukemia effect of resveratrol", Leukemia and Lymphoma, 43, 983-987.
20. Baell, J.B. and Huang, D.C. (2002) "Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs", Biochemical Pharmacology, 64, 851-863.
21. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., et al. (1991) "p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia", Proceedings of the National Academy of Sciences, 88, 5413-5417.
22. Drexler, H.G., Fombonne, S., Matsuo, Y., Hu, Z.B., Hamaguchi, H. and Uphoff, C.C. (2000) "p53 alterations in human leukemia-lymphoma cell lines: vitroartifact or prerequisite for cell immortalization?" Leukemia, 14, 198-206.
23. Scaffidi, C., Medema, J.P., Krammer, P.H. and Peter, M.E. (1997) "Flice is predominantly expressed as two functionally active isoforms, Caspase 8/a and Caspase 8/b", Journal Biological Chemistry, 272, 26953-26955.
24. Bae, J., Leo, C.P., Hsu, S.Y. and Hseueh, J.W. (2000) "MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a pro-apoptotic protein possessing only the BH3 domain", Journal of Biological Chemistry, 275, 25255-25261.
25. Gutierrez, M.I., Cherney, B., Hussain, A., Mostowski, H., Tosato, G., et al. (1999) "Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis", Cancer Research, 59, 696-703.
26. Meijerink, J.P., Mensink, E.J., Wang, K., Sedlak, T.W., Sloetjes, A.W., de Witte, T., et al. (1998) "Hematopoetic malignancies demonstrate loss-of-function mutations of Bax", Blood, 9, 2991-2997.
27. Korsmeyer, S.J., Wei, M.C., Saito, M., Weiler, S., Oh, K.J. and Schlesinger, P.H. (2000) "Pro-apoptotic cascade activates BID, which oligomerizes BAK BAX into pores that result in the release in cytochrome c", Cell Death and Differentiation, 7, 1166-1173.
28. Shiramizu, B., Barriga, F., Neequaye, J., Jafri, A., Dalla-Favera, R., Neri, A., et al. (1991) "Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association", Blood, 77, 1516-1526.
29. Bhatia, K.G., Gutierrez, M.I., Huppi, K., Siwarski, D. and Magrath, I.T. (1992) "The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors", Cancer Research, 52, 4273-4276.
30. O'Connor, P.M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I. and Kohn, K.W. (1993) "Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines", Cancer Research, 53, 4776-4780.
31. Hussain, A., Doucet, J.P., Gutiérrez, M.I., Ahmad, M., Al-Hussein, K., Capello, D., et al. (2003) "Tumor necrosis factor Related Apoptosis Inducing Ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins", Haematologica, 88, 167-175.
32. Eggert, A., Grotzer, M.A., Zuzak, T.J., Wiewrodt, B.R., Ho, R., Ikegaki, N. et al. (2001) "Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression", Cancer Research, 61, 1314-1319.